Proteome Sciences (LON:PRM) Shares Down 2.7% – Time to Sell?

Proteome Sciences plc (LON:PRM)’s stock price traded down 2.7% on Tuesday . The stock traded as low as GBX 3.60 ($0.05) and last traded at GBX 3.60 ($0.05). 1,183,886 shares traded hands during mid-day trading, an increase of 573% from the average session volume of 175,815 shares. The stock had previously closed at GBX 3.70 ($0.05).

Proteome Sciences Stock Performance

The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37. The stock has a market cap of £11.51 million, a P/E ratio of -2.82 and a beta of 0.07. The stock has a 50-day simple moving average of GBX 4.10 and a 200-day simple moving average of GBX 3.43.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.